|
Thursday 21st November 2019 |
Text too small? |
Maxigesic painkiller manufacturer AFT Pharmaceuticals is starting to deliver on the growth strategy funded by its 2015 NZX listing, with sales in South East Asia rocketing ahead in the first six months of this year and in line with company expectations in the six months to Sept. 30. While growth...
Read the full story at BusinessDesk
https://businessdesk.co.nz/article/aft-pharmaceuticals-starts-to-hit-its-straps
No comments yet
MCY - Mercury Green Bond offer - interest rate set
March 25th Morning Report
AFT - Chief Financial Officer update
KMD Brands: Response to Stokehouse transaction concept
March 24th Morning Report
MCY - Mercury launches retail Green Bond offer
Fonterra delivers another strong result for HY26
March 23th Morning Report
Devon Funds Morning Note - 18 March 2026
TRA - Turners updates earnings guidance